Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Follow us on Twitter

  • The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients… https://t.co/68QuQj2ik5
    about 7 hours ago
  • New post on Science and Enterprise: FDA Clears Stem Cell Trial for Multiple Sclerosis https://t.co/iLohWcDKEC #Science #Business
    about 7 hours ago
  • A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer's… https://t.co/YBoAZKBjBw
    about 1 day ago
  • New post on Science and Enterprise: Alzheimer’s Digital Biomarkers Project Gains New Funds https://t.co/lxhfwd4Bzi #Science #Business
    about 1 day ago
  • Shionogi starts clinical test on oral COVID drug | NHK WORLD-JAPAN News https://t.co/EAQvk9nGjw
    about 2 days ago

Please share Science & Enterprise

Alzheimer’s Digital Biomarkers Project Gains New Funds

Brain circuits illustration

A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer’s disease and other forms of dementia. . . . → Read More: Alzheimer’s Digital Biomarkers Project Gains New Funds

Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds

Red blood cells illustration

A start-up company creating synthetic blood vessels for transplants, based on research in materials science and cell biology, is raising $2.2 million in seed funds. . . . → Read More: Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds

ALS Drug Maker Gains $135M in New Funds

Man in wheelchair

A developer of treatments for people with amyotrophic lateral sclerosis, or ALS, is raising $135 million in its third venture financing round. . . . → Read More: ALS Drug Maker Gains $135M in New Funds

Infographic – 2021 Black Start-Up Funding Rises

Investments in Black-founded companies

Venture funding for Black-owned start-ups in the U.S. rose to record levels in the first half of 2021, but the percentage of total funding remains low. . . . → Read More: Infographic – 2021 Black Start-Up Funding Rises

Immune Cell Cancer Biotech Gains $172M in New Funds

Natural killer cell

A biotechnology company developing cancer therapies with natural killer cells in the immune system is raising $172 million in its second venture round. . . . → Read More: Immune Cell Cancer Biotech Gains $172M in New Funds

$60M Challenge Seeks RNA Bio-Production Network

Gene therapy graphic

A new challenge competition aims to build a distributed network of facilities to design, develop, and manufacture RNA-based biologic products. . . . → Read More: $60M Challenge Seeks RNA Bio-Production Network

Precision Gene-Editing Biotech Gains $200M in New Funds

David Liu

A biotechnology company says it discovers therapies with the gene-editing technique Crispr to carry out a wider range of precise genomic corrections. . . . → Read More: Precision Gene-Editing Biotech Gains $200M in New Funds

Infographic – U.S. Leads Record Q2 Venture Funding

Venture investments Q2 2021

Venture capital financing broke global records in the second quarter of 2021, with investments in the U.S. accounting for nearly half of all dollars invested. . . . → Read More: Infographic – U.S. Leads Record Q2 Venture Funding

Neuro Disease Start-Up Raises $73M in Early Funds

Nerve cells illustration

A new enterprise discovering treatments for neurodegenerative diseases is merging with another start-up and raising $73 million its first venture round. . . . → Read More: Neuro Disease Start-Up Raises $73M in Early Funds

Infographic – Biotech Index Rebounds in Q2

Nasdaq Biotech Index

Since mid-May, NBI rose steadily, closing at 5,148 by the end of June, a gain of nine percent for the quarter and eight percent for the year. . . . → Read More: Infographic – Biotech Index Rebounds in Q2